Decheng Capital
About Us
Team
Portfolio
News
Contact
A Global Life Sciences Investment Firm
Established in 2012
$2.1 Billion of Capital
Building Legendary Companies
In The News
December 17, 2019
KeChow Completes $45 Million Round for Novel Cancer Drug Development
December 17, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
December 4, 2019
Hummingbird Bioscience Raises US$19 Million in Series B Financing
November 4, 2019
SinoMed, a Medical Device Company, Stages $50 Million IPO on the Shanghai STAR Exchange
October 25, 2019
BeyondSpring Announces Pricing of Ordinary Shares
August 29, 2019
Sema4 Lands New Investors, Continues to Expand
August 12, 2019
AtriCure offers $300m for SentreHeart
July 17, 2019
BeyondSpring Announces Pricing of Public Offering of Ordinary Shares
July 17, 2019
Adaptive Biotechnologies Announces Pricing of Initial Public Offering
July 17, 2019
EpimAb Biotherapeutics Raises $74M in Series B Financing
May 17, 2019
Hangzhou's AnHeart Completes $14.6 Million A Funding from Decheng
February 14, 2019
Bioheng Closes $15 Million Funding from Decheng Capital for CAR-T Products
January 16, 2019
Alpine Immune Sciences Announces $25 Million Private Placement
January 3, 2019
Mindstrong Health Expands Series B Financing with $31M Investment led by General Catalyst
Archive
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012